Nanjing Medlander Medical Technology Co. Ltd. A (688273) — Cash Flow-to-Debt Ratio
Nanjing Medlander Medical Technology Co. Ltd. A (688273) has a Cash Flow-to-Debt Ratio of 0.61x as of December 2024, meaning its operating cash flow of CN¥122.51 Million could theoretically repay 1% of its total liabilities (CN¥199.66 Million) in one year. See 688273 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Nanjing Medlander Medical Technology Co. Ltd. A Cash Flow-to-Debt Ratio (2020–2024)
Historical debt coverage capacity for Nanjing Medlander Medical Technology Co. Ltd. A across 5 annual periods. For the full cash flow conversion analysis, see 688273 operating cash flow.
Annual Cash Flow-to-Debt Ratio for Nanjing Medlander Medical Technology Co. Ltd. A (2020–2024)
Year-by-year debt coverage analysis for Nanjing Medlander Medical Technology Co. Ltd. A. Check 688273 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.61x | CN¥122.51 Million | CN¥199.66 Million | ▼ -28.9% |
| 2023 | 0.86x | CN¥136.91 Million | CN¥158.60 Million | ▼ -3.3% |
| 2022 | 0.89x | CN¥126.67 Million | CN¥141.96 Million | ▼ -30.3% |
| 2021 | 1.28x | CN¥148.60 Million | CN¥116.01 Million | ▼ -13.3% |
| 2020 | 1.48x | CN¥131.10 Million | CN¥88.69 Million | — |